Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): Report on 3-year tumor control and normal tissue toxicity

Radiotherapy and Oncology

Volumn 58, Issue 2, 2001, Pages 121-130

  Lee, Anne W M ^a   Sze, Wai Man ^a   Yau, Tsz Kok ^a   Yeung, Rebecca M W ^a   Chappell, Rick ^b   Fowler, John F ^c  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Accelerated fractionation; Conventional fractionation; Nasopharyngeal neoplasm

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CONFIDENCE INTERVALS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NECK; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PHARYNX; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 0035252323     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00312-1     Document Type: Article

References (43)

1. Superiority of chemo-radiotherapy (CT-RT) vs. radiotherapy (RT) in patients with locally advanced nasopharyngeal cancer (NPC)
2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099
3. Impact of spinal cord repair kinetics on the practice of altered fractionation schedules
4. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy
5. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer
6. A randomized multicenter trial of CHART versus conventional radiotherapy for head and neck cancer
7. Loss of local control with prolongation in radiotherapy
8. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
9. Importance of overall time for the outcome of radiotherapy of advanced head and neck carcinoma: Dependency on tumor differentiation
10. Influence of radiotherapy treatment time on control of laryngeal cancer: Comparisons between centers in Manchester, UK and Toronto, Canada
11. TNM classification of malignant tumors
12. Nasopharynx
13. Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: Problem of local relapse and influence of overall treatment time
14. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
15. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
16. Nasopharyngeal cancer: Study II
17. VUMCA I Trial. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (< N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
18. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancers
19. Nonparametric estimation from incomplete observations
20. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients
21. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma
22. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma
23. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure
24. Caution on the use of altered fractionation for nasopharyngeal carcinoma
25. Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: Incidence and determinants
26. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma
27. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx
28. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation
29. Split-course radiation therapy of carcinoma of the nasopharynx: Results of a national collaborative clinical trial of the Radiation Therapy Oncology Group
30. Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions/week - Report from DAHANCA7 Trial
31. Elapsed treatment days - A critical item for radiotherapy quality control review in head and neck trials: RTOG report
32. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
33. Carcinoma of the nasopharyngeal treated by radiotherapy alone: Determinants of local and regional control
34. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - Report on 3-year tumor control and normal tissue toxicity
35. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy
36. Pharynx
37. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation
38. Early tumor response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma
39. Patterns of failure in carcinoma of the nasopharynx: 1. Failure at the primary site
40. Carcinoma of the nasopharynx
41. The hazard of accelerated tumor clonogen repopulation during radiotherapy
42. Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions